Imugene (ASX:IMU) Marketable Securities: A$0.04 Mil (As of Dec. 2025)


ASX:IMU Imugene Ltd ASX:IMU
30 GF Score
Price A$0.11
! 4 Warning Signs
View Full Analysis

What is Imugene Marketable Securities?

Imugene ASX:IMU 30 Marketable Securities is A$0.04 Mil as of Dec. 2025. GuruFocus rates ASX:IMU with a GF Score™ of 30/100. The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Imugene's Marketable Securities for the quarter that ended in Dec. 2025 was A$0.04 Mil.

Imugene  (ASX:IMU) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Imugene Marketable Securities Related Terms

Imugene Marketable Securities Historical Data

* Premium members only.

The historical data trend for Imugene's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imugene Marketable Securities Chart

Imugene Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Imugene Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 1.59 0.00 0.04
ASX:IMU
30GF Score
Imugene Ltd ASX:IMU
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imugene Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of A$0.04 Mil mean?
Imugene (ASX:IMU) has a Marketable Securities of A$0.04 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Imugene and its competitors.
Is Imugene's Marketable Securities too high?
Imugene's current Marketable Securities is A$0.04 Mil. Overall, Imugene has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Imugene's Marketable Securities compare to VRTX and REGN?
Imugene's Marketable Securities of A$0.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Imugene and its competitors. Imugene's current Marketable Securities is A$0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imugene stock overvalued right now?
Imugene (ASX:IMU) has a current Marketable Securities of A$0.04 Mil. The current Marketable Securities is A$0.04 Mil. Imugene's overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Imugene (ASX:IMU), the current Marketable Securities is A$0.04 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imugene Business Description

Other Exchanges IUGNF:USAILA:Germany
Address 4-6 Bligh Street, Suite 12.01, Level 12, Sydney, NSW, AUS, 2000
Imugene Ltd is a clinical stage immuno-oncology company developing a range of new treatments that seek to activate the immune system of cancer patients to identify and eradicate tumours. Its products include HER-Vaxx, PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment is the Research and Development of oncolytic immunotherapies.
30GF Score

Get the complete analysis for ASX:IMU

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.11
Price